PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis

Nephrology Dialysis Transplantation

Volumn 18, Issue 6, 2003, Pages 1142-1146

  Aucella, Filippo ^a   Margaglione, Maurizio ^a,b   Vigilante, Mimmo ^a   Gatta, Giuseppe ^a   Grandone, Elvira ^a   Forcella, Mauro ^c   Ktena, Maria ^c   De Min, Alva ^c   Salatino, Giovanna ^c   Procacinni, Deni Aldo ^c   Stallone, Carmine ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c NONE

Author keywords

ACE; Dialysis; Genetics; Mortality; Myocardial infarction; PAI 1

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIALYSIS; FEMALE; FOLLOW UP; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HEMODIALYSIS; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; DNA TRANSPOSABLE ELEMENTS; FEMALE; GENOTYPE; HUMANS; ITALY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDYL-DIPEPTIDASE A; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS;

EID: 0037670184     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg118     Document Type: Article

References (27)

1. Goldbourt U, Neufeld HN. Genetic aspect of arteriosclerosis. Arteriosclerosis 1986; 6: 357-377
2. Shea S, Ottman R, Gabrieli C, Stein Z, Nichols A. Family history as an independent risk factor for coronary artery disease. J Am Coll Cardiol 1984; 4: 793-801
3. Hamstein A, deFaire U, Walldius G et al. Plasminogen activator inhibitor in plasma: risk for recurrent myocardial infarction. Lancet 1987; 2: 3-9
4. Kohler H, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 2000; 342: 1792-1801
5. Malik FS, Lavie CJ, Mehra M. Milani RV, Re RN. Renin-angiotensin system: genes to bedside. Am Heart J 1997; 134: 514-526
6. Vaughan DE. The renin-angiotensin system and fibrinolysis. Am J Cardiol 1997; 79: 12-16
7. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Convol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346
8. Eriksson P, Kallin B, van't Hoft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor-1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 1995; 92: 1851-1855
9. Aucella F, Vigilante M, Margaglione M et al. Polymorphism of the Angiotensin-Converting Enzyme gene in end stage renal failure patients. Nephron 2000; 85: 54-59
10. Mancini FP, Margaglione M, Tufano A et al. A fast and accurate method for genotyping the angiotensin-converting-enzyme I/D polymorphism. Circulation 1998; 97: 1213-1214
11. Margaglione M, Cappuci G, Colaizzo D et al. The PAI-1 gene locus 4G/5G is associated with a family history of coronary artery disease. Arterioscl Thromb Vasc Biol 1998; 18: 152-156
12. Zoccali C. Cardiovascular risk in uremic patients-is it fully explained by classical risk factors? Nephrol Dial Transplant 2000; 15: 454-457
13. Samani N, Thompson IR, Otoole L, Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin converting enzyme gene with myocardial infarction. Circulation 1996; 94: 708-712
14. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993; 268: 10739-10745
15. Gardemann A, Lohre J, Katz N, Tillmanns H, Wilhelm Hehrlein F, Haberbosch W. The 4G4G genotype of the plasminogen activator inhibitor 4G/5G polymorphisms is associated with coronary atherosclerosis in patients at high risk for this disease. Thromb Haemost 1999; 82: 1121-1126
16. Irish AB. Plasminogen activator inhibitor-1 activity in chronic renal disease and dialysis. Metabolism 1997; 46: 36-40
17. Doggen CJM, Bertina RM, Manger Cats V, Reitsma PH, Rosendaal FR. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction. Thromb Haemost 1999; 82: 115-120
18. Iacoviello L, Burzotta F, Di Castelnuovo A, Zito F, Marchiali R, Donati MB. The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis. Thromb Haemost 1998; 80: 1029-1030
19. Gris JC, Branger B, Vecina F, Al sabadani B, Fourcade J, Schved JF. Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients. Kidney Int 1994; 46: 807-813
20. Segarra A, Chacon P, Martinez-Eyarre C et al. Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients:biochemical correlations and role as independent predictors of coronary artery stenosis. J Am Soc Nephrol 2001; 12: 1255-1263
21. Ando R, Doi M, Yamauchi K, Chida Y, da T, Endo K, Yanagi H, Tomura S. Association of β-fibrinogen and factor VII polymorphism with plasma fibrinogen and factor VII levels, and no association of PAI-1 polymorphism with plasma PAI-1 levels in hemodialysis patients. Clin Nephrol 2002; 58: 25-32
22. Cambien F, Poirier O, Lecerf L et al. Deletion polymorphism in the gene for angiotensin convertine enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644
23. Yong TYH, Poon P, Szeto CC, Chan JCN, Li PKT. Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients. Kidney Int 2000; 57: 632-638
24. Kimura H, Gejyo F, Suzuki S, Suzuki S, Miyazaki R, Arakawa M. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy. Kidney Int 1998; 54: 1659-1669
25. Yoshida H, Kon V, Ichikawa I. Polymorphism of the renin angiotensin system genes in progressive renal diseases. Kidney Int 1996; 50: 732-744
26. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Chen D, Passa P, Froguel P. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin dependent diabetes mellitus. Proc Natl Acad Sci USA 1994; 91: 3662-3665
27. Butler R. The DD-ACE genotype and cardiovascular disease. Pharmacogenomics 2000; 1: 153-167